We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$974M
AUM Growth
+$19.6M
Cap. Flow
+$2.06M
Cap. Flow %
0.21%
Top 10 Hldgs %
28.45%
Holding
269
New
9
Increased
54
Reduced
125
Closed
8

Top Buys

Rank Stock Value
1
ALTR
Altera Corp
ALTR
+$17.4M
2
CLB icon
Core Laboratories
CLB
+$9.79M
3
VOD icon
Vodafone
VOD
+$6.24M
4
KN icon
Knowles
KN
+$3.41M
5
FWONA icon
Liberty Media Series A
FWONA
+$2.43M

Top Sells

Rank Stock Value
1
GLW icon
Corning
GLW
+$10.5M
2
TXN icon
Texas Instruments
TXN
+$7.49M
3
INTC icon
Intel
INTC
+$6.38M
4
CSCO icon
Cisco
CSCO
+$4.6M
5
LAYN
Layne Christensen Co
LAYN
+$4.38M

Sector Composition

Rank Sector Weight
1 Technology 20.07%
2 Industrials 16.59%
3 Healthcare 12.13%
4 Consumer Discretionary 11.91%
5 Energy 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SABA
151
Saba Capital Income & Opportunities Fund II
SABA
$221M
$659K 0.07%
39,950
CRR
152
DELISTED
Carbo Ceramics Inc.
CRR
$658K 0.07%
4,275
-600
-12% -$82.7K
PPT
153
Franklin Premier Income Trust
PPT
$323M
$652K 0.07%
117,500
+6,000
+5% +$33.2K
UL icon
154
Unilever
UL
$133B
$652K 0.07%
12,800
-356
-3% -$17.8K
XBI icon
155
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$631K 0.06%
12,300
-600
-5% -$27.1K
MJN
156
DELISTED
Mead Johnson Nutrition Company
MJN
$614K 0.06%
6,600
BMY icon
157
Bristol-Myers Squibb
BMY
$129B
$613K 0.06%
12,650
SYT
158
DELISTED
Syngenta Ag
SYT
$589K 0.06%
7,875
-200
-2% -$15.4K
ORBK
159
DELISTED
Orbotech Ltd
ORBK
$567K 0.06%
37,400
ORI icon
160
Old Republic International
ORI
$10.4B
$545K 0.06%
32,975
BHI
161
DELISTED
Baker Hughes
BHI
$541K 0.06%
7,270
-200
-3% -$13.9K
VE
162
DELISTED
VEOLIA ENVIRONNEMENT
VE
$536K 0.06%
28,250
-400
-1% -$7.7K
PFL
163
PIMCO Income Strategy Fund
PFL
$383M
$529K 0.05%
42,900
+950
+2% +$11.4K
CROX icon
164
Crocs
CROX
$6.69B
$523K 0.05%
34,845
VTN icon
165
Invesco Trust for Investment Grade New York Municipals
VTN
$162M
$481K 0.05%
34,000
VTRS icon
166
Viatris
VTRS
$20.4B
$477K 0.05%
9,270
AEP icon
167
American Electric Power
AEP
$73.7B
$468K 0.05%
8,401
-300
-3% -$15.8K
MERC icon
168
Mercer International
MERC
$44.2M
$462K 0.05%
44,000
-3,500
-7% -$30.5K
SLB icon
169
SLB Ltd
SLB
$77.6B
$456K 0.05%
3,870
-1,000
-21% -$103K
MS icon
170
Morgan Stanley
MS
$335B
$452K 0.05%
14,000
+2,200
+19% +$67.8K
AAL icon
171
American Airlines Group
AAL
$9.66B
$449K 0.05%
10,462
+4,147
+66% +$162K
BNY
172
Bank of New York Mellon
BNY
$107B
$442K 0.05%
11,800
P
173
DELISTED
Pandora Media Inc
P
$442K 0.05%
15,000
RAND icon
174
Rand Capital
RAND
$30.4M
$439K 0.05%
15,422
+55
+0.4% +$1.66K
PFN
175
PIMCO Income Strategy Fund II
PFN
$692M
$435K 0.04%
39,400

Similar funds

Shufro Rose & Co's Q2 2014 Portfolio in Review

As of Q2 2014, Shufro Rose & Co held 269 positions worth $974M, up 2.1% from $955M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Shufro Rose & Co's Q2 2014 filing shows 9 new, 54 increased, 125 reduced and 8 closed positions. Its largest new stake was Altera Corp: 515,915 shares worth $17.9M. The largest sale was Corning, an estimated $10.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Shufro Rose & Co's largest Q2 2014 buy was Altera Corp: 515,915 shares worth $17.9M.
  • Shufro Rose & Co added most to Vodafone in Q2 2014, an estimated $6.24M increase.
  • Shufro Rose & Co's biggest Q2 2014 reduction was Corning, cutting an estimated $10.5M.
  • Shufro Rose & Co fully exited Layne Christensen Co in Q2 2014, selling an estimated $4.38M.
  • Shufro Rose & Co's ten largest holdings make up 28% of its $974M portfolio in Q2 2014.
  • Shufro Rose & Co opened 9 new positions and closed 8 in Q2 2014.
  • Shufro Rose & Co's portfolio value rose 2.1% quarter-over-quarter to $974M.

Based on Shufro Rose & Co's 13F filing for Q2 2014, filed 31 Jul 2014.